Identification of actionable mutations in surgically resected tumor specimens from Japanese patients with non-small cell lung cancer by ultra-deep targeted sequencing.

Authors

null

Yasuhiro Koh

Division of Drug Discovery and Development, Shizuoka Cancer Center Research Institute, Nagaizumi-chou, Shizuoka, Japan

Yasuhiro Koh , Hirotsugu Kenmotsu , Masakuni Serizawa , Mitsuhiro Isaka , Keita Mori , Hisao Imai , Hiroaki Akamatsu , Akira Ono , Tateaki Naito , Tetsuhiko Taira , Haruyasu Murakami , Toshiaki Takahashi , Masahiro Endo , Takashi Nakajima , Yasuhisa Ohde , Nobuyuki Yamamoto

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Local-Regional Non–Small Cell Lung Cancer

Citation

J Clin Oncol 31, 2013 (suppl; abstr 7572)

DOI

10.1200/jco.2013.31.15_suppl.7572

Abstract #

7572

Poster Bd #

24B

Abstract Disclosures

Similar Posters

Poster

2018 ASCO Annual Meeting

Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.

Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.

First Author: Razelle Kurzrock

First Author: Hirotsugu Kenmotsu